Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021 | Infectious Diseases | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.187.155. Please contact the publisher to request reinstatement.
1.
Daly  M, Robinson  E.  Willingness to vaccinate against COVID-19 in the US: representative longitudinal evidence from April to October 2020.   Am J Prev Med.2021;60(6):766-773. doi:10.1016/j.amepre.2021.01.008 Google ScholarCrossref
2.
Szilagyi  PG, Thomas  K, Shah  MD,  et al.  National trends in the US public’s likelihood of getting a COVID-19 vaccine—April 1 to December 8, 2020.   JAMA. 2020;325(4):396-398. doi:10.1001/jama.2020.26419 PubMedGoogle ScholarCrossref
3.
Robinson  E, Jones  A, Lesser  I, Daly  M.  International estimates of intended uptake and refusal of COVID-19 vaccines: a rapid systematic review and meta-analysis of large nationally representative samples.   Vaccine. 2021;39(15):2024-2034. doi:10.1016/j.vaccine.2021.02.005 PubMedGoogle ScholarCrossref
4.
Kapteyn  A, Angrisani  M, Bennett  D,  et al  Tracking the effect of the COVID-19 pandemic on the lives of American households.   Surv Res Methods. 2020;14(2):179-186. doi:10.18148/srm/2020.v14i2.7737Google Scholar
5.
Lopez  L  III, Hart  LH  III, Katz  MH.  Racial and ethnic health disparities related to COVID-19.   JAMA. 2021;325(8):719-720. doi:10.1001/jama.2020.26443PubMedGoogle ScholarCrossref
6.
Gold  JAW, Rossen  LM, Ahmad  FB,  et al.  Race, ethnicity, and age trends in persons who died from COVID-19—United States, May–August 2020.   MMWR Morb Mortal Wkly Rep. 2020;69(42):1517-1521. doi:10.15585/mmwr.mm6942e1 PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Views 16,005
    Citations 0
    Research Letter
    May 24, 2021

    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021

    Author Affiliations
    • 1Department of Psychology, Maynooth University, Kildare, Ireland
    • 2Department of Psychology, University of Liverpool, Liverpool, United Kingdom
    • 3Institute of Population Health Sciences, University of Liverpool, Liverpool, United Kingdom
    JAMA. 2021;325(23):2397-2399. doi:10.1001/jama.2021.8246

    The development of vaccines showing high efficacy against SARS-CoV-2 has offered a way to protect against the health effects of the virus. Yet national surveys suggest that willingness to vaccinate declined throughout 2020 and may be insufficient to provide population immunity.1-3 Public trust in the development of vaccines and the government approval process represents a potential crucial reason for this hesitancy. This study tested changes in trust in vaccination and vaccine hesitancy.

    Participants were from 7 waves of the probability-based Understanding America Study (UAS) of US adults,2,4 conducted between October 14, 2020, and March 29, 2021. The UAS is an internet panel in which panel members are invited to complete questionnaires every 14 to 28 days; internet-connected tablets are provided to households if necessary. The response rate from panel members in this study was 75% to 79% (Supplement).

    ×